Premium
Clinical activity of ibrutinib in classical Hodgkin lymphoma relapsing after allogeneic stem cell transplantation is independent of tumor BTK expression
Author(s) -
Badar Talha,
Astle John,
Kakar Imran K.,
Zellner Katie,
Hari Parameswaran N.,
Hamadani Mehdi
Publication year - 2020
Publication title -
british journal of haematology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.907
H-Index - 186
eISSN - 1365-2141
pISSN - 0007-1048
DOI - 10.1111/bjh.16738
Subject(s) - ibrutinib , transplantation , stem cell , lymphoma , medicine , bruton's tyrosine kinase , cancer research , oncology , hodgkin lymphoma , immunology , leukemia , biology , chronic lymphocytic leukemia , tyrosine kinase , receptor , genetics
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom